PHR Stock Overview
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Phreesia, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.41 |
| 52 Week High | US$34.98 |
| 52 Week Low | US$12.05 |
| Beta | 0.92 |
| 1 Month Change | -2.65% |
| 3 Month Change | -11.25% |
| 1 Year Change | -31.68% |
| 3 Year Change | -57.72% |
| 5 Year Change | n/a |
| Change since IPO | -10.65% |
Recent News & Updates
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Recent updates
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27Are Phreesia, Inc. (NYSE:PHR) Investors Paying Above The Intrinsic Value?
Nov 08Is It Time To Consider Buying Phreesia, Inc. (NYSE:PHR)?
Sep 15Phreesia (PHR) Investor Presentation - Slideshow
Jun 16Shareholder Returns
| PHR | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -2.6% | -4.7% | -3.2% |
| 1Y | -31.7% | -13.6% | 19.3% |
Return vs Industry: PHR underperformed the US Healthcare Services industry which returned -13.6% over the past year.
Return vs Market: PHR underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| PHR volatility | |
|---|---|
| PHR Average Weekly Movement | 6.6% |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHR's share price has been volatile over the past 3 months.
Volatility Over Time: PHR's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,438 | Chaim Indig | www.phreesia.com |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients’ mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks.
Phreesia, Inc. Fundamentals Summary
| PHR fundamental statistics | |
|---|---|
| Market cap | US$1.26b |
| Earnings (TTM) | -US$136.88m |
| Revenue (TTM) | US$356.30m |
3.5x
P/S Ratio-9.2x
P/E RatioIs PHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHR income statement (TTM) | |
|---|---|
| Revenue | US$356.30m |
| Cost of Revenue | US$124.01m |
| Gross Profit | US$232.29m |
| Other Expenses | US$369.17m |
| Earnings | -US$136.88m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.43 |
| Gross Margin | 65.19% |
| Net Profit Margin | -38.42% |
| Debt/Equity Ratio | 1.3% |
How did PHR perform over the long term?
See historical performance and comparison